Rhumbline Advisers Clear Point Neuro, Inc. Transaction History

Rhumbline Advisers

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$5.25 - $6.73 $86,325 - $110,661	-16,443 Reduced 74.06%	5,759 $31,000
Q1 2024 May 09, 2024	BUY	$6.03 - $7.86 $6,693 - $8,724	1,110 Added 5.26%	22,202 $150,000
Q4 2023 Feb 08, 2024	SELL	$4.46 - $7.07 $41,321 - $65,503	-9,265 Reduced 30.52%	21,092 $143,000
Q3 2023 Nov 09, 2023	BUY	$5.01 - $7.09 $10,651 - $15,073	2,126 Added 7.53%	30,357 $152,000
Q2 2023 Aug 08, 2023	BUY	$6.54 - $10.58 $184,630 - $298,683	28,231 New	28,231 $204,000
Q2 2022 Aug 11, 2022	SELL	$7.09 - $13.65 $125,358 - $241,345	-17,681 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$7.8 - $11.6 $37,923 - $56,399	4,862 Added 37.93%	17,681 $184,000
Q4 2021 Feb 10, 2022	SELL	$11.08 - $18.86 $3,700 - $6,299	-334 Reduced 2.54%	12,819 $144,000
Q3 2021 Nov 12, 2021	BUY	$16.58 - $22.25 $20,708 - $27,790	1,249 Added 10.49%	13,153 $233,000
Q2 2021 Aug 05, 2021	BUY	$17.23 - $22.77 $205,105 - $271,054	11,904 New	11,904 $227,000

6.81M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $400M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.